Page last updated: 2024-11-07

norethindrone acetate and Intestinal Diseases

norethindrone acetate has been researched along with Intestinal Diseases in 2 studies

norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.

Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.

Research Excerpts

ExcerptRelevanceReference
"This patient preference prospective study was designed to compare patients' satisfaction in women with endometriosis treated either by an extended-cycle oral contraception (OC) or by norethindrone acetate (NETA)."3.88Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique ( Barra, F; Ferrero, S; Leone Roberti Maggiore, U; Scala, C; Venturini, PL, 2018)
"Gastrointestinal angiodysplasias are the most common cause of obscure chronic digestive blood loss."1.29Diagnostic efficacy of push-enteroscopy and long-term follow-up of patients with small bowel angiodysplasias. ( Adler, M; Cremer, M; Gay, F; Schmit, A; Van Gossum, A, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scala, C1
Leone Roberti Maggiore, U1
Barra, F1
Venturini, PL1
Ferrero, S1
Schmit, A1
Gay, F1
Adler, M1
Cremer, M1
Van Gossum, A1

Other Studies

2 other studies available for norethindrone acetate and Intestinal Diseases

ArticleYear
Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique
    European journal of obstetrics, gynecology, and reproductive biology, 2018, Volume: 222

    Topics: Adult; Contraceptives, Oral, Synthetic; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female;

2018
Diagnostic efficacy of push-enteroscopy and long-term follow-up of patients with small bowel angiodysplasias.
    Digestive diseases and sciences, 1996, Volume: 41, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiodysplasia; Combined Modality Therapy; Drug Therapy,

1996